{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03313",
    "Peptide Name": "SyCPA 4 (gladiosyn, chemically synthetic AMPs20; XXL, Lys-rich; lipopeptide; XXD3; lactam; XXJ; UCSB1a; BBW)",
    "Source": "bioinformatic predicted bacterial nonribosomal gene cluster,Burkholderia gladioliBSR3, chr 2, bacteria-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "AKSKRKGV",
    "Sequence Length": 8,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 4,
    "Boman Index": 3.52,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "25%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Discovery: the peptide was predicted but made in a different way.Sequence analysis: APD analysis reveals this sequence is most similar (44.44%) toCr-ACP1Chemical modification: N-terminus coupled with tetradecanoic acid (surragate of S or T in the original sequence) to facilitate sidechain cyclization; Residues S3, R5, and V8 are D-amino acids (XXD3).Activity: active against B. subtilis 168 1A1 (MIC 8 ug/ml), E. faecium Com15 (MIC 64 ug/ml), S. aureus USA300 (MIC 64 ug/ml), E-coli DH5alpha (MIC>64 ug/ml), K-pneumoniae ATCC 10031 (MIC>64 ug/ml), A-baumannii ATCC 17978 (MIC>64 ug/ml), P-aeruginosa PAO1 (MIC>64 ug/ml), E-cloacae ATCC 14037 (MIC>64 ug/ml), M-tuberculosis H37RV (MIC>12.5 ug/ml).MOA: inhibits cell wall synthesis. Reg. 12/2021",
    "Author": "Chu J, Koirala B, Forelli N, Vila-Farres X, Ternei MA, Ali T, Colosimo DA, Brady SF. 2020",
    "Reference": "J Am Chem Soc. 2020 Aug 19;142(33):14158-14168. doi: 10.1021/jacs.0c04376.PubMed",
    "Title": "Synthetic-Bioinformatic Natural Product Antibiotics with Diverse Modes of Action."
  },
  "3D Structure": []
}